Cure Childhood Cancer

Current Research Initiatives

And the research continues. This fiscal year we are allocating $2.5 million in Pediatric Research Grants and Fellowships to support scientists at:

  • The Aflac Cancer Center and Blood Disorders Center of Children’s Healthcare of Atlanta
  • Emory University
  • MD Anderson Cancer Center

For fiscal year 2013-2014, CURE is supporting 16 specific projects, most of which focused on finding effective treatments for the 20% of kids who do not survive childhood cancer.

Click here to view a report on the research funded during fiscal year 2013-2014.

Researcher(s): Area of Study: Research Summary:

Dr. Caspary Medulloblastoma Developing drug therapies to successfully block a genetic protein commonly found in high-risk medulloblastoma (MD) tumors.
Dr. Castellino Medulloblastoma Continuation of the study of the wp1 gene in medulloblastoma and the development of drug therapies for chemotherapy-resistant tumors and prevention of tumor metastasis for potential future clinical trials.
Dr. Gu Neuroblastoma Use of MX69 into drug therapies to treat pediatric neuroblastoma.
Dr. Van Meir Ewing Sarcoma Development of new drug therapies to treat Ewing sarcoma.
Dr. Zhou Acute Lymphoblastic Leukemia Researching potential drugs to block the MDM2-MDM4 interaction to treat acute lymphoblastic leukemia (ALL) patients.
Dr. Kennedy Medulloblastoma Developing therapeutic approaches to isolate proteins that cause cancer tumor growth in MD patients.
Dr. Gilleland Survivorship Feasibility study of adolescent and young adult cancer survivors and their use of Cancer SurvivorLink to access and utilize electronic personal health record (ePHR) and other resources as they transition to adult care.
Dr. Shehata Renal Tumors A new project to inventory and analyze renal tumor tissues for future research and presentation.
Dr. Aguilara Glioma Phase II study of PEG-interferon in pediatric patients with refractory and progressive low grade glioma (LGG)
Dr. Mertens
Dr. Record
Survivorship A feasibility study to determine if telemedicine is effective in improving access to pediatric survivorship care closer to home
Dr. Kleinerman Osteosarcoma The preclinical trial development of NK cell therapy and aerosol IL-2 for relapsed osteosarcoma.
Dr. MacDonald Brain and Spinal Cord Tumors Research initiatives at the Children’s Brain and Spinal Cord Tumor Program
Dr. Lee
Dr. Sanders
Brain Tumors Clinical trial testing the potential of NK (natural killer) cells in pediatric brain tumors
Dr. Kleinerman Osteosarcoma Pre-clinical trial development of NK cell therapy and aerosol IL-2 for relapsed osteosarcoma
2 Pediatric Oncology Fellowships Aflac Cancer Center at Children’s Healthcare of Atlanta CURE granted the Aflac Cancer Center with funding to support two pediatric oncologist fellowships, one fully funded by The Sam Robb Fund.
Equipment Aflac Cancer Center at Children’s Healthcare of Atlanta CURE also provided Aflac Cancer Center with funding for the purchase of new imaging equipment for the research labs.
“CURE is extremely pleased to be partnering with these scientists to continue our search
for cures and better treatments for children with cancer and to improve the quality of life of childhood cancer survivors. CURE has a 38-year-long history of supporting promising research, and we are proud to continue that effort.”
- Kristin Connor, Executive Director












  • 06-300x199


    Register for the 5K/10K on September 13th at the Suwanee Town Center in Suwanee, GA, and CURE will receive a $5 donation! This race is also a Peachtree Road Race qualifier. Click here to learn more.

  • Screen Shot 2014-05-21 at 12.46.17 PM


    Purchase tables or tickets for this unique concert experience, held at Chukkar Farm in Marietta, GA. A portion of proceeds from ticket sales for 8/1 and 8/2 will benefit CURE. Click here to learn more and purchase tickets.